Drug Research

Contract development and manufacturing organization (CDMO), Stelis BioSource, a division of Stelis Biopharma, has started the next phase of its continued investment program after having already invested more than $100 million into its facilities in Bangalore, India. The latest phase...

Transcenta, a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, and Merck, a leading science and technology company, have announced a strategic technology collaboration to implement continuous manufacturing for protein therapeutics at CIIE. “To...

Oxford Biomedica plc , a leading gene and cell therapy group and PhoreMost Limited, the UK-based biopharmaceutical company dedicated to developing drugs against intractable disease targets, announced that they have entered into a discovery collaboration to develop next-generation CAR-T...

Thermo Fisher Scientific Inc., the world leader in serving science, and Innoforce, a bioinnovation-enabling company, announced they have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and steriles drug...

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced the expansion of its Maryland campus to accommodate the company’s rapid growth as it works to develop its candidate vaccine against COVID-19 and advance its...

aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, announced that it has entered into a research collaboration with the Medical University of South Carolina (MUSC). Dr....

Intec Pharma Ltd. announces it has entered into a new research collaboration agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth, NJ, USA. Details of the agreement are confidential. "We are very excited to continue to work with...